Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) for Recurrent Head and Neck Cancer
Status:
Recruiting
Trial end date:
2021-03-01
Target enrollment:
Participant gender:
Summary
Clinical experience of with hyperthermia combined with radiotherapy and chemotherapy for
recurrent head and neck cancer is limited. The primary goals of hyperthermia combined with
CCRT on recurrent head and neck cancer are tumor response rate, while secondary goals are
rates of acute and late adverse effects, local control rate, distant metastasis rate,
progression-free rate and overall survival rate.